Next, we performed targeted resequencing of the novel candidate CRC susceptibility genes EMR3, PTPN12 and LRP6 using an Ion Ampliseq custom panel (Life technologies, see Materials and Methods for details) and a replication cohort of 174 CRC cases (Table 1). Here, PTPN12 is linked to colorectal carcinoma.